CTA genes have been shown previously to lose methylation and become derepressed in several cancer cell types after treatment with the methyltransferase inhibitor 5′aza-2-deoxycytidine (Aza) [64–66] and in the HCT116 DNMT1 mutant line [66, 67] using locus-specific approaches. This evidence concerns the gene DNMT1 and cancer.